Pfizer Submits Vaccine For Emergency Use Authorization

The vaccine, reportedly 95 percent effective, could be available next month if it is approved for use. NBC's Sarah Dallof reports.

(NBC News) — Pfizer has submitted an application for Emergency Use Authorization of their COVID-19 vaccine.

Distribution could begin within 24 hours once that authorization is granted by the U.S. Food and Drug Administration.

Pfizer and their partner Biontech say the vaccine was successful in 95 percent of the patients enrolled in clinical trials.

The FDA will analyze Pfizer’s raw clinical and manufacturing data ahead of an advisory committee meeting scheduled for December.

Moderna is reporting similar rates in the vaccine it’s developing.

The news comes at a critical time, with more than 193,000 people reporting new COVID-19 infections in the U.S. Thursday, a new record.

One in five hospitals nationwide are reporting staffing shortages.

Read more here.